Lista de obras - Andrea Bonetti - Dominio Público Uruguay

Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?

artículo científico publicado en 2015

Ampulla of Vater carcinoma in real-world clinical practice: a case series.

artículo científico publicado en 2015

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis

artículo científico publicado en 1997

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.

artículo científico publicado en 2015

Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly.

artículo científico publicado en 2013

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

artículo científico publicado en 2016

Cisplatin versus cetuximab given concomitantly with radiotherapy in non-resectable head and neck squamous cell carcinoma: an open question

scientific article published on 25 February 2015

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

artículo científico publicado en 2016

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

artículo científico publicado en 2009

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.

artículo científico publicado en 2015

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

artículo científico publicado en 2015

Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice

artículo científico publicado en 2017

Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs

artículo científico publicado en 2017

Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis

artículo científico publicado en 1992

Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

artículo científico publicado en 2013

Hepatic artery infusion for liver metastases from colorectal cancer.

artículo científico publicado en 2003

High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.

artículo científico publicado en 1993

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

artículo científico publicado en 2011

Late recurrence (more than 10 years) in early (tumors equal to or smaller than 2 cm) breast cancer patients

artículo científico publicado en 2015

Management of advanced pancreatic cancer in daily clinical practice.

artículo científico publicado en 2015

Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs

artículo científico publicado en 2017

Off-label prescription of anti-cancer drugs in Italy: what responsibilities?

artículo científico publicado en 2013

Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.

artículo científico publicado en 1998

Pharmacokinetics of an extended-release human interferon alpha-2b formulation

scientific article published on 01 January 1993

Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials

artículo científico publicado en 2015

Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

artículo científico publicado en 2015

Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question.

artículo científico publicado en 2015

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial ⬇️

artículo científico publicado el 23 de mayo de 2011

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

artículo científico publicado en 2004

Re: Michal Sarfaty, Moshe Leshno, Noa Gordon, et al. Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.07.041: Second-line Treatment in Metastatic Renal Cell Carcinoma. Can

scientific article published on 31 October 2017

Rhabdoid carcinoma of the colon: a distinct entity with a very aggressive behavior: a case report associated with a polyposis coli and review of the literature.

artículo científico

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

artículo científico publicado en 2015

Second-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

artículo científico publicado en 2017

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating e

artículo científico publicado en 2016

The Multidisciplinary Management of Cancer in Daily Clinical Practice: Towards a Community Hospital Comprehensive Cancer Center.

artículo científico publicado en 2016

The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies

artículo científico

The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors.

artículo científico publicado en 2016

The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials

artículo científico publicado en 2016

The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials

artículo científico publicado en 2016

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.

artículo científico publicado en 2013

The effect of palliative care on the assistance of terminally ill cancer patients

scientific article published on 08 June 2013

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients treated with targeted agents.

artículo científico publicado en 2016

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials

artículo científico publicado en 2014

The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction

artículo científico publicado en 2016

Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".

artículo científico publicado en 2015

Trends in survival for patients with metastatic breast cancer: is survival improving?

artículo científico publicado en 2015

Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience.

artículo científico publicado en 2011

Lista de obras de Andrea Bonetti

Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?

Ampulla of Vater carcinoma in real-world clinical practice: a case series.

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.

Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly.

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

Cisplatin versus cetuximab given concomitantly with radiotherapy in non-resectable head and neck squamous cell carcinoma: an open question

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice

Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs

Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis

Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

Hepatic artery infusion for liver metastases from colorectal cancer.

High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

Late recurrence (more than 10 years) in early (tumors equal to or smaller than 2 cm) breast cancer patients

Management of advanced pancreatic cancer in daily clinical practice.

Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs

Off-label prescription of anti-cancer drugs in Italy: what responsibilities?

Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.

Pharmacokinetics of an extended-release human interferon alpha-2b formulation

Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials

Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question.

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial ⬇️

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

Re: Michal Sarfaty, Moshe Leshno, Noa Gordon, et al. Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.07.041: Second-line Treatment in Metastatic Renal Cell Carcinoma. Can

Rhabdoid carcinoma of the colon: a distinct entity with a very aggressive behavior: a case report associated with a polyposis coli and review of the literature.

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

Second-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating e

The Multidisciplinary Management of Cancer in Daily Clinical Practice: Towards a Community Hospital Comprehensive Cancer Center.

The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies

The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors.

The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials

The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.

The effect of palliative care on the assistance of terminally ill cancer patients

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients treated with targeted agents.

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials

The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction

Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".

Trends in survival for patients with metastatic breast cancer: is survival improving?

Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience.